Your browser doesn't support javascript.
loading
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.
Solanich, Xavier; Rigo-Bonnin, Raúl; Gumucio, Victor-David; Bastard, Paul; Rosain, Jérémie; Philippot, Quentin; Perez-Fernandez, Xosé-Luis; Fuset-Cabanes, Maria-Paz; Gordillo-Benitez, Miguel-Ángel; Suarez-Cuartin, Guillermo; Boza-Hernandez, Enric; Riera-Mestre, Antoni; Parra-Martínez, Alba; Colobran, Roger; Antolí, Arnau; Navarro, Sergio; Rocamora-Blanch, Gemma; Framil, Mario; Calatayud, Laura; Corbella, Xavier; Casanova, Jean-Laurent; Morandeira, Francisco; Sabater-Riera, Joan.
Afiliação
  • Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. xsolanich@bellvitgehospital.cat.
  • Rigo-Bonnin R; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. xsolanich@bellvitgehospital.cat.
  • Gumucio VD; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Bastard P; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rosain J; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Philippot Q; Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Perez-Fernandez XL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
  • Fuset-Cabanes MP; Imagine Institute, University of Paris, Paris, EU, France.
  • Gordillo-Benitez MÁ; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Suarez-Cuartin G; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
  • Boza-Hernandez E; Imagine Institute, University of Paris, Paris, EU, France.
  • Riera-Mestre A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
  • Parra-Martínez A; Imagine Institute, University of Paris, Paris, EU, France.
  • Colobran R; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Antolí A; Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Navarro S; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rocamora-Blanch G; Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Framil M; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Calatayud L; Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Corbella X; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Casanova JL; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Morandeira F; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sabater-Riera J; Department of Anesthesiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
J Clin Immunol ; 41(8): 1733-1744, 2021 11.
Article em En | MEDLINE | ID: mdl-34570326

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Interferon Tipo I / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Interferon Tipo I / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article